menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Reforming the FDA: Perspectives from the Pew Charitable Trusts

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Comments
  • Overview

    This week, hosts Mark Masselli and Margaret Flinter speak with Allan Coukell, Sr. Director for Health Programs at the Pew Charitable Trusts, where he oversees the FDA, drug and medical device safety and the opioid crisis. He discusses suggested changes to the FDA made by the Trump Administration, and how best to promote reforms at the US Food and Drug Administration to better respond to 21st century advances in research and discovery.

Facebook Comments

Recommended
Details
Comments
  • Overview

    This week, hosts Mark Masselli and Margaret Flinter speak with Allan Coukell, Sr. Director for Health Programs at the Pew Charitable Trusts, where he oversees the FDA, drug and medical device safety and the opioid crisis. He discusses suggested changes to the FDA made by the Trump Administration, and how best to promote reforms at the US Food and Drug Administration to better respond to 21st century advances in research and discovery.

Facebook Comments

Schedule14 Apr 2024